Stay updated on XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.

Latest updates to the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision (v3.3.2) was added to the record history and an older revision (v3.2.0) was removed from the list; these are minor metadata updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page no longer displays the government funding lapse notice at the top; the rest of the content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check39 days agoChange DetectedVersion 2 (2022-05-17) updated Recruitment Status; Version 3 (2022-08-28) updated Study Status.SummaryDifference0.1%

- Check68 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

- Check75 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check89 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.8%

Stay in the know with updates to XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.